• Profile
Close

Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial

American Journal of Psychiatry Jun 03, 2019

Carmi L, et al. - Recently a dysfunction of the cortical-striatal-thalamic-cortical circuit has been thought to play a role in obsessive-compulsive disorder (OCD) and a prior feasibility study proposed a benefit targeting the medial prefrontal cortex and the anterior cingulate cortex with deep transcranial magnetic stimulation (dTMS), so researchers conducted this multicenter double-blind sham-controlled study investigating the therapeutic effect of dTMS in these patients. Random allocation of 99 OCD patients to treatment with either high-frequency (20 Hz) or sham dTMS was done at 11 centers. For 6 weeks, patients received daily treatments following individualized symptom provocation. At the 1-month follow-up, the active treatment group exhibited response rates of 45.2% and the sham treatment group exhibited response rates of 17.8%. OCD symptoms could be significantly improved with high-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex and for those who do not respond sufficiently to pharmacological and psychological interventions, it could be considered as a potential intervention.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay